Full Press Release Details
Solid Biosciences Provides Third Quarter Business Update And.
SLDB
Solid Biosciences Provides Third Quarter Business Update And
Key Takeaway: Solid Biosciences Provides Third Quarter Business Update And
Price reaction · baseline $2.8 (2023-11-07 close) · hit after-hours · 2 other SLDB headline(s) in the window, move may be shared
day 0 close
-0.4%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+116%
120-day peak, hindsight
Typical move
7.4%
average across 7 past catalysts
Cash runway
~21 mo
Low dilution risk
Lead asset
carmustine
Phase 3 · Lymphoma